Abstract
Reactive oxygen species (ROS) and reactive nitrogen species (RNS) are generally thought to be important mediators of various pathological conditions. Since fluorescent probes are promising tools for clarifying the functions of biomolecules in biological systems as demonstrated by the case of Ca2+ fluorescent probes, interest in the use of fluorescent probes for sensing ROS/RNS is increasing. Although fluorescent probes such as 2,7-dichlorodihydrofluorescein (DCFH) and dihydrorhodamine 123 (DHR123) have traditionally been used for sensing ROS/RNS, many reports suggest that such probes are not suitable for sensing specific ROS/RNS individually but for whole oxidative stresses caused by ROS/RNS due to their lack of selectivity for ROS/RNS. However, it is quite important to detect specific ROS/RNS with a high selectively because each ROS/RNS has its own physiological activities and has unique characteristic roles. To achieve such specificity, novel functional fluorescent probes that can distinguish specific ROS/RNS individually with high selectivity, have been developed in recent years. The purpose of this review is to highlight recent advances in the design and development of such selective ROS/RNS fluorescent probes that should have a great potential for evaluating the unique roles of individual ROS/RNS in biological processes.
Keywords: Fluorescent probe, reactive oxygen species (ROS), reactive nitrogen species (RNS), molecular imaging
Current Bioactive Compounds
Title: Sensing Reactive Oxygen and Nitrogen Species Using Selective Fluorescent Probes
Volume: 2 Issue: 4
Author(s): Nobuaki Soh and Toshihiko Imato
Affiliation:
Keywords: Fluorescent probe, reactive oxygen species (ROS), reactive nitrogen species (RNS), molecular imaging
Abstract: Reactive oxygen species (ROS) and reactive nitrogen species (RNS) are generally thought to be important mediators of various pathological conditions. Since fluorescent probes are promising tools for clarifying the functions of biomolecules in biological systems as demonstrated by the case of Ca2+ fluorescent probes, interest in the use of fluorescent probes for sensing ROS/RNS is increasing. Although fluorescent probes such as 2,7-dichlorodihydrofluorescein (DCFH) and dihydrorhodamine 123 (DHR123) have traditionally been used for sensing ROS/RNS, many reports suggest that such probes are not suitable for sensing specific ROS/RNS individually but for whole oxidative stresses caused by ROS/RNS due to their lack of selectivity for ROS/RNS. However, it is quite important to detect specific ROS/RNS with a high selectively because each ROS/RNS has its own physiological activities and has unique characteristic roles. To achieve such specificity, novel functional fluorescent probes that can distinguish specific ROS/RNS individually with high selectivity, have been developed in recent years. The purpose of this review is to highlight recent advances in the design and development of such selective ROS/RNS fluorescent probes that should have a great potential for evaluating the unique roles of individual ROS/RNS in biological processes.
Export Options
About this article
Cite this article as:
Soh Nobuaki and Imato Toshihiko, Sensing Reactive Oxygen and Nitrogen Species Using Selective Fluorescent Probes, Current Bioactive Compounds 2006; 2 (4) . https://dx.doi.org/10.2174/157340706778992645
DOI https://dx.doi.org/10.2174/157340706778992645 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Bioactive Heterocycles from Domino Wittig-Pericyclic Reactions
Current Organic Chemistry Hypertension to Heart Failure: New Developmental Strategies do not Cross a Clinical and Therapeutic Divide
Current Pharmaceutical Design Bone: A Fertile Soil for Cancer Metastasis
Current Drug Targets Antihypertensive Drug Treatment and Circadian Blood Pressure Rhythm: A Review of the Role of Chronotherapy in Hypertension
Current Pharmaceutical Design Editorial: Understanding Basic Muscle Electrophysiology While Keeping an Eye on Diseases of the Heart, Lung and Blood
Recent Patents on Cardiovascular Drug Discovery Endothelial Dysfunction and Angiogenesis in Autosomal Dominant Polycystic Kidney Disease
Current Hypertension Reviews Buxus sempervirens L. Improves Lipid Profile in Diabetic Rats
Cardiovascular & Hematological Disorders-Drug Targets The Ryanodine Receptor: A Pivotal Ca2+ Regulatory Protein and Potential Therapeutic Drug Target
Current Drug Targets A Comparative Study of Marketing Authorization of Drug Eluting Coronary Stents (DES) in India and Developed Countries (USA & EU)
Applied Clinical Research, Clinical Trials and Regulatory Affairs Stem Cell-Derived Motor Neurons: Applications and Challenges in Amyotrophic Lateral Sclerosis
Current Stem Cell Research & Therapy Role of Bisphosphonates in Vascular calcification and Bone Metabolism: A Clinical Summary
Current Cardiology Reviews Ligands of Diltiazem Binding Site: An Overview of Some Chemotypes
Mini-Reviews in Medicinal Chemistry On Electromagnetic Ablation of Biological Tissues: A Review
Recent Patents on Electrical Engineering Recent Developments on Coronary Microvasculopathy after Heart Transplantation:A New Target in the Therapy of Cardiac Allograft Vasculopathy
Current Vascular Pharmacology Clinical Uses of 1-alpha-hydroxycholecalciferol
Current Vascular Pharmacology Diabetes and Vascular Disease: Basic Concepts of Nitric Oxide Physiology, Endothelial Dysfunction, Oxidative Stress and Therapeutic Possibilities
Current Vascular Pharmacology The Importance of Gender Differences in the Diagnosis and Management of Cardiovascular Disease
Current Pharmaceutical Design Novel Paramagnetic Contrast Agents for Molecular Imaging and Targeted Drug Delivery
Current Pharmaceutical Biotechnology Prostacyclin, Atherothrombosis and Diabetes Mellitus: Physiologic and Clinical Considerations
Current Molecular Medicine Targeting Complement in Rheumatoid Arthritis
Current Rheumatology Reviews